Inspiration Healthcare Group

About Inspiration Healthcare Group

Inspiration Healthcare Group PLC is a global medical technology company headquartered in the UK that designs, manufactures, and markets devices for neonatal intensive care, critical care, and operating theatres. The company was founded in 2003 by Neil Campbell, who has over two decades of experience in the medical device industry. He led the company as CEO, including through its reverse acquisition of Inditherm plc and listing on the AIM market of the London Stock Exchange in 2015, before stepping down in 2024. Raffi Stepanian, a former GE Healthcare leader, was appointed CEO in January 2025.

The company's business model is centered on developing and selling its own branded products, where it holds the intellectual property, alongside distributing third-party products. This creates a mix of one-off sales from capital equipment and recurring revenue from single-use disposables. The business operates through three main segments: Acute Care (including neonatal intensive care and operating theatre equipment), Infusion Therapy (distributing infusion technologies in the UK and Ireland), and Service (maintenance, repairs, and spare parts). The company sells its products directly in the UK and Ireland and through a network of distributors in over 75 countries worldwide.

Inspiration Healthcare's product portfolio is focused on improving outcomes for vulnerable patients, particularly premature infants. Key products include the SLE6000 neonatal ventilator, the Tecotherm Neo for patient warming and cooling, and the LifeStart bedside resuscitation unit. The company also offers ambulatory infusion pumps and systems for applications like oncology, palliative care, and parenteral nutrition. The company has pursued growth through acquisitions, including S.L.E. Ltd, a manufacturer of neonatal ventilators, and Airon, a ventilator specialist.